In recent years, a large body of evidence has indicated that locally produced growth and differentiation factors are involved Recent measurements of circulating inhibin A and inhibin in regulating follicle development. Among the growing list of B concentrations indicate that inhibin B may play an regulators are the inhibins and activins. Inhibins and activins important role in the selection of dominant follicles. The are dimeric proteins produced by ovarian follicles with the concentrations of inhibin A, inhibin B and activin A were capability of modulating pituitary FSH secretion. There are measured in the follicular fluids of 61 individual follicles two forms of inhibin composed of a common α-subunit coupled (4.8-20 mm in diameter) from 47 regularly cycling women with one of two β-subunits: inhibin A (αβ A ), and inhibin B using specific two-site enzyme-linked immunosorbent (αβ B ). Activins are homodimers of β-subunits and can be assays. The microenvironment of each follicle was characfound in three forms: activin A (β A β A ), activin B (β B β B ), and terized by measuring follicular fluid androstenedione and activin AB (β A β B ). In addition to their effects on FSH secretion, oestradiol concentrations. The mean activin A concentrathere is evidence supporting a local autocrine/paracrine regutions were <8 ng/ml for follicles of all sizes (4-17 mm).
latory role in ovarian follicles. Inhibin A concentrations were <1 ng/ml in follicles <6 mm, Data from studies in a variety of animal species have and progressively increased to concentrations >50 ng/ml in provided evidence that activin A and inhibin A have opposing follicles 13 mm. Follicles with androstenedione/oestradiol paracrine effects on follicle development. Activin A retards ratios ≤4 had higher concentrations of inhibin A than follicle growth in rat (Woodruff et al., 1990) , marmoset (Miro follicles with androstenedione/oestradiol ratios >4. Inhibin and Hillier, 1992) , and sheep (McNeilly et al., 1991) ovaries, B concentrations were higher than inhibin A concentrations whereas inhibin promotes follicle development. Although actiin all follicles, increasing from 19.2 ⍨ 8.3 ng/ml in 4 mm vin A has been shown to exert its actions directly on rat (Miro follicles to 409 ⍨ 9.6 ng/ml in 13 mm follicles and then and Hillier, 1992) and marmoset (Smyth et al., 1994 ) granulosa declining to 275 ⍨ 47 ng/ml in 17 mm follicles. These cells, the effects of inhibin A appear to involve stimulation of results support the hypothesis that inhibin B may play a thecal androgen production in ewes, rats and human females more important paracrine role in developing follicles and (Hsueh et al., 1987; Hillier et al., 1991; McNeilly et al., 1991) . a greater regulatory role with respect to follicle stimulating It has been proposed that the dominant follicle secretes hormone (FSH) secretion than inhibin A.
increasing amounts of inhibin and oestradiol throughout the Key words: activin/follicular fluid/inhibin/ovary follicular phase of the menstrual cycle and thereby causes the decline in circulating FSH concentrations that occurs during the second half of the follicular phase (Zeleznik and FairchildIntroduction Benyo, 1994) . The stimulatory actions of molecules such as inhibin are likely to be critical for sensitizing the dominant In order for ovulation to occur, the cells in an ovarian follicle must complete a specific programme of growth and follicle to FSH. Because of its increased sensitivity and responsiveness to FSH, the dominant follicle is thought to differentiation. During the final stages of development, the follicles contain a fluid-filled antrum. Characterization of the maintain its rapid growth and development to the pre-ovulatory stage, even though circulating FSH concentrations decline contents of the follicular fluid has provided a window into the microenvironment of the developing follicle. Measurements (Zeleznik and Fairchild-Benyo, 1994) . Although the inhibins are endocrine hormones that suppress of steroid and gonadotrophic hormone concentrations in human follicular fluid have shown that dominant follicles destined to pituitary FSH secretion, measurements of circulating inhibin A concentrations have not demonstrated the expected rise ovulate contain an oestrogenic microenvironment with an androstenedione:oestradiol ratio ഛ4 (McNatty et al., 1979;  during the follicular phase of the human menstrual cycle (Groome et al., 1996) . The lack of an endocrine role for inhibin Brailly et al., 1981) . Follicles destined to undergo atresia have A is further supported by the observation that neutralizing antibodies to inhibin A administered to female stumptailed macaques during the luteal phase failed to alter circulating FSH concentrations (Fraser and Tsonis, 1994) . In these same experiments, injection of 200 µg of recombinant human inhibin A on day 3 or 4 of the follicular phase also failed to alter FSH concentrations. Inhibin A secretion does, however, seem to be correlated with luteinization of granulosa cells (Eramaa and Ritvos, 1996) . Prostaglandin E 2 , a luteotrophic regulator produced by the human corpus luteum, has been shown to stimulate inhibin α and β A subunit mRNA expression as well as increase dimeric inhibin A secretion by luteinized granulosa cells (Eramaa and Ritvos, 1996) . In contrast, circulating inhibin B concentrations rise to a peak at mid-follicular phase and then decline slightly toward mid-cycle (Groome et al., 1996) . This pattern of inhibin concentrations is much more closely Although inhibin has been measured in the follicular fluid of pre-ovulatory follicles (Franchimont et al., 1990) and inhibin B concentrations have been shown to be much higher in the fluids were measured by specific radioimmunoassays as previously described (Magoffin and Erickson, 1982) .
Inhibin A, inhibin B and activin A were measured using specific
Materials and methods
ELISA kits (Serotec Limited, Oxford, UK) and the ELISA Amplification System (Life Technologies, Inc., Gaithersburg, MD, USA) Subjects according to the manufacturer's protocols. These assays are based on Ovarian tissue specimens were obtained from 61 individual follicles previously published methods for measuring inhibin A .0 mm) from 47 regularly cycling pre-menopausal women et al., 1994) , inhibin B (Groome and Illingworth et al., 1996) and undergoing total abdominal hysterectomy and bilateral oophorectomy activin A (Muttukrishna et al., 1996) . For the inhibin assays, follicular for non-ovarian indications unrelated to the study (Table I ). The mean fluid samples and the standards were diluted in post-menopausal age of the subjects was 34.4 years (range 19-44). None of the subjects human serum. For the activin A assay, the follicular fluid and had received hormonal therapy or ovarian suppression for at least 3 standards were diluted in 5% BSA in phosphate buffered saline. The months prior to obtaining the samples. All subjects were in the intra-and inter-plate coefficients of variation were Ͻ7% for each assay. follicular phase of their menstrual cycles. Serum steroid and gonadotrophin concentrations were consistent with normal follicular phase Statistical analysis values. Informed consent was obtained from all subjects participating Differences between groups were analysed by analysis of variance in the study as approved by the Ethics Committee at the University followed by Tukey's test. The level of statistical significance was School of Medicine in Lublin. These studies were also approved by considered to be P Ͻ 0.05. the IRB at Cedars-Sinai Medical Center. Follicular fluid steroid concentrations and FSH-like bioactivity measured by the rat granulosa cells aromatase bioassay (limit of detection ϭ 0.2 mIU/ml) as well women are shown in Figure 1 . The concentrations of inhibin B were greater than inhibin A (P Ͻ 0.001), which were Follicular fluid collection generally higher than activin A. Activin A concentrations were
The ovarian specimens were immediately placed into ice-cold Medium-199 (GIBCO-BRL, Gaithersburg, MD) containing 25 mM low in follicles of all diameters. Inhibin A concentrations were A in the follicular fluid of some follicles. There was a significant increase in inhibin A as follicle diameter increased (r ϭ 0.826; P Ͻ 0.001). All of the follicles with androstenedione/oestradiol ratios ഛ4 had higher inhibin A in the follicular low in follicles 10 mm and smaller but gradually increasing. The mean inhibin A concentrations were 4-6 fold higher (P Ͻ fluid than the basal concentrations found in 4-5 mm follicles. The pattern of inhibin B concentrations in the follicular 0.001) in follicles ജ13 mm than in follicles Ͼ10 mm. In contrast to inhibin A and activin A, the inhibin B concentrafluid of individual follicles was markedly different from either Ͻ0.2 mIU/ml in the follicular fluid and oestradiol concentrations were also low. Interestingly, there were examples of follicles Ͼ8 mm in diameter that had high concentrations of inhibin B (Ͼ200 ng/ml) in the follicular fluid but androstenedione/oestradiol ratios Ͼ4. Unlike most of the larger follicles (which have androstenedione/oestradiol ratios ഛ4) these follicles had undetectable concentrations (Ͻ0.2 mIU/ml) of bioactive FSH in the follicular fluid. Thus it appears that elevated inhibin alone is not sufficient to stimulate an oestrogenic microenvironment and promote follicular dominance. Surprisingly, there were extremely low concentrations of inhibin B in the follicular fluid of the 20 mm follicle. There were similarly low concentrations of bioactive FSH in the follicular fluid of this follicle as well, yet the androstenedione/oestradiol ratio was 0.6. circulation decline from early follicular phase concentrations approximately two-fold to a nadir at the mid-follicular phase and then return to early follicular phase concentrations by inhibin A or activin A ( Figure 5 ). While there was considerable variation in the concentrations between individual follicles of mid-cycle (Muttukrishna et al., 1996) . The mean concentrations in the follicular fluid changed very little in follicles of any similar diameter, the concentrations in follicles with androstenedione/oestradiol ratios ഛ4 tended to be higher than in size but there was at least a two-fold variation in follicular fluid concentrations in follicles of each size. It therefore follicles with androstenedione/oestradiol ratios Ͼ4. Nevertheless there were occasional follicles in which high inhibin, high remains unclear why activin A concentrations decline at the mid-follicular phase, or the extent to which the variation in FSH and an oestrogenic microenvironment were not all present. There were four follicles Ͻ8 mm in diameter with androstenecirculating concentrations is physiologically significant. In the case of inhibin A, circulating concentrations are low dione/oestradiol ratios Ͼ4 and inhibin B concentrations Ͼ200 ng/ml. All of these follicles had bioactive FSH concentrations throughout most of the follicular phase of the menstrual cycle and rise dramatically beginning in the late follicular phase, A inhibits follicle growth whereas inhibin promotes follicle development (Woodruff et al., 1990; McNeilly and Crow et al. , with a peak in the mid-luteal phase (Muttukrishna et al., 1996; Groome et al., 1996) . Inhibin A concentrations in the follicular 1991; Miro and Hillier, 1992) , it is likely that these follicles would undergo atresia. fluid of small and medium sized antral follicles were low and gradually increased in large dominant follicles. The data also
Follistatin is an activin-binding protein produced by ovarian granulosa cells (Findlay, 1993) . Measurements of follistatin in indicate that the dominant follicle produces more inhibin A in the follicular phase than cohort follicles. Nevertheless, a human follicular fluid indicate that there are approximately 200 ng/ml of follistatin in small antral follicles and preovulatory significant proportion of the total inhibin A produced by the ovary could originate in cohort follicles. The difference in follicles (Erickson et al., 1995) . There does not appear to be significant variation in the follicular fluid concentrations of inhibin A concentrations in the dominant and cohort follicles is relatively small and there are likely to be several cohort follistatin with follicle diameter, dominance or atresia (Erickson et al., 1995) . The high concentration of follistatin indicates follicles present in the ovaries compared to the single dominant follicle.
that the majority of activin A is likely to be bound to follistatin in antral follicles. Since follistatin has been shown to antagonize The changes in inhibin B were the most striking and correlated closely with the pattern of circulating inhibin B.
the actions of activin on ovarian cells (Findlay, 1993) , it is probable that activin A plays only a minor regulatory role in The circulating concentrations of inhibin B are at their lowest concentration in the late luteal phase and at the beginning of antral follicles. The physiological role of inhibin in the selection of the the follicular phase. Circulating inhibin B rises markedly to a plateau by the mid-follicular phase and then declines somewhat dominant follicle remains to be proven, but there are several pieces of information suggesting that inhibin may be important. prior to a mid-cycle peak (Groome et al., 1996) . Follicular fluid concentrations of inhibin B were lowest in small antral First, it has been proposed that the decline in FSH concentrations beginning in the mid-follicular phase is critical for follicles and rose over 20-fold to a peak in 13 mm follicles then declined slightly in larger follicles. Interestingly, the selection of a single dominant follicle (Zeleznik and FairchildBenyo, 1994) . When the largest developing follicle grows concentrations of inhibins and activin were very low in the one 20 mm follicle measured. Bioactive FSH concentrations beyond~7 mm in diameter, it begins to accumulate FSH in the follicular fluid and secrete oestradiol (McNatty and Baird, were undetectable in this follicle as well (Jakimiuk et al., unpublished data) . If this proves to be a consistent pattern, 1978; McNatty and Smith et al., 1979; Jakimiuk et al., unpublished data) . As the present studies have shown, there is also this observation suggests that the follicular contents are released prior to ovulation and could play a role in the mid-cycle peak a significant rise in inhibin B concentrations in the follicular fluid. The combination of inhibin B and oestradiol signal to of inhibin B that was measured in the circulation (Groome et al., 1996) . The data also suggest that the majority of inhibin the hypothalamus/pituitary that an emerging dominant follicle is present and suppression of FSH secretion begins. Since B produced by the ovary during the follicular phase originates in the dominant follicle due to the large difference in the follicle growth beyond~8 mm in women is dependent on FSH, it is critical that the dominant follicle has adequate FSH amounts produced by large antral follicles with androstenedione/oestradiol ratios ഛ4 compared to cohort follicles with stimulation, otherwise the follicle will undergo atresia. To prevent atresia, the dominant follicle produces intrafollicular androstenedione/oestradiol ratios Ͼ4. These data support the hypothesis that inhibin B is more physiologically important regulators such as insulin-like growth factor I that amplify the stimulatory effects of FSH only in the dominant follicle. for regulating pituitary FSH secretion during the follicular phase of the cycle than inhibin A. This conclusion is based Thus, the dominant follicle gains an important developmental advantage over the cohort follicles. Ultimately, the dominant on several observations. First, increases in inhibin B concentrations are correlated with decreases in circulating FSH, whereas follicle will ovulate and the cohort follicles will undergo atresia due to inadequate FSH support. inhibin A concentrations are not. Second, manipulations of circulating inhibin A concentrations do not alter circulating
The endocrine role of the inhibins has yet to be proven. Experiments in monkeys in which circulating inhibin A concen-FSH in monkeys (Fraser and Tsonis, 1994) . Third, the majority of inhibin B is produced by the dominant follicle, and fourth, trations were decreased using a neutralizing antibody or increased by administering recombinant inhibin A failed to the amounts of inhibin B produced by the ovary in the follicular phase are far higher than inhibin A.
alter circulating FSH concentrations (Fraser and Tsonis, 1994) . These data support the concept that inhibin A may not In the great majority of follicles, the activin A concentrations were within the same range, but there were a minority of 4-8 have an important endocrine role. Similar studies need to be performed to demonstrate an endocrine role for inhibin B. mm follicles in which the activin A concentrations were somewhat elevated. It is unclear why these follicles were Nevertheless, the data are convincing that inhibin A and activin can play roles as autocrine and paracrine modulators of different; however, they all had non-detectable levels of FSH bioactivity and the inhibin A and B concentrations were among follicular differentiation and steroidogenesis (Hillier, 1991; Findlay, 1993) . the lowest measured. The possibility exists that the activin concentrations were elevated relative to the other follicles
In-vitro studies in the rat indicate that the granulosa cells of small antral follicles secrete paracrine factors that are because production of the inhibin α-subunit may have been low. The physiological significance of the elevated activin A inhibitory to thecal androgen production (Zachow and Magoffin, 1995) . Under the influence of FSH, the granulosa concentrations is unknown. Based on the evidence that activin
